Diagnostic accuracy of Calypte HIV-1 Urine EIA kit in Pakistan
Abstract
Background: HIV is one of the major public health issues of modern world. The elevation in numbers calls for increased and efficient diagnostic testing protocols. A great number of HIV diagnostic tests have been approved and in use in the developed world but developing countries are still lagging in terms of testing HIV. These reasons are the motives behind this study which is aimed at testing the accuracy and use of Calypte HIV-1 Urine EIA in the Pakistani population.
Methods: 516 subjects are included in the study from different HIV centers of Pakistan. The test results of Calypte-HIV-1 Urine EIA were compared with the routinely used 3-kit method.
Results: The results exhibited 100% specificity but low sensitivity (74.67%). However, the positive predictive value and negative predictive value were 100% and 52.94%, respectively. Overall accuracy result for this kit was observed to be 81.40% for Calypte HIV-1 Urine EIA in the selected sample.
Conclusion: Pakistan has a low population prevalence of HIV and keeping in view of the WHO recommended guidelines for HIV testing, the use of Calypte HIV-1 Urine EIA is not ideal in the current scenario. Even though the test can be of great value in high prevalence populations and can be an excellent means of surveillance procedures, it is not as fit to be used in diagnostic settings in the current situation in developing countries.
Full Text:
PDFReferences
Salih H, Salih A, Ahmed R. Bioactivity of Cymbopogon Citratus aqueous extract against measles virus and some bacterial isolates. Caspian Journal of Environmental Sciences, (2022); 20(3): 585-592.
International Agency for Research on Cancer(IARC). GLOBOCAN http://gco.iarc.fr/tomorrow/home (2018).
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of cancer, (2020); 127: 2893–2917.
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecologic Oncology Reports, (2015); 136; 178–182.
Isa Modibbo F, Dareng E, Bamisaye P, Jedy-Agba E, Adewole A, Oyeneyin L. et al. Qualitative study of barriers to cervical cancer screening among Nigerian women. BMJ Open, (2016); 6: e008533.
Khalili Tanha, G., Barzegar, A., Shokrzadeh, M., Nikbakhsh, N., Ansari, Z. Correlation between serum concentration of diazinon pesticide and breast cancer incidence in Mazandaran Province, northern Iran. Caspian Journal of Environmental Sciences, (2020); 18(3): 197-204.
Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. European Journal of Cancer, (2009);45: 2640–2648.
Refaei M, Dehghan Nayeri N, Khakbazan Z, Pakgohar M. Cervical Cancer Screeningin Iranian Women: Healthcare Practitioner Perceptions and Views. Asian Pacific Journal of Cancer Prevention, (2017); 18(2): 357-63.
HSalih, A., H Salih, R., Y Ahmed, H. Bioactivity of Cymbopogon Citratus aqueous extract against measles virus and some bacterial isolates. Caspian Journal of Environmental Sciences, (2022); 20(3): 585-592.
Sharifi M, Mohammadi Z, Makvandi Z, Rostami P, Moradi A. Assessment of cervical cancer screening and its barriers in 18-50 year old women referring to Asad Abad comprehensive health centers. Planetry Science Journal, (2018); 16 (2): 35-45.
Farzaneh E, Heydari H, Shekarchi A, Kamran A. Breast and cervical cancer-screening uptake among females in Ardabil, northwest Iran: a community-based study. OncoTargets and Therapy, (2017);10 :985-92
Bakht R, Shobairi F, Roshanaei GH, Fakori E. Factors Affecting the Screening of Cervical Cancer in Addicted Women in Hamadan in 2017: Based on the Model of Protection Motivation Theory. Hakim Seyed Esmail Jorjani Journal, (2017); (2)4: 1-3.
Mussavi, M., Asadollahi, K., Janbaz, F., Mansoori, E., Abbasi, N. The evaluation of red reflex sensitivity and specificity test among neonates in different conditions. Iranian Journal of Pediatrics. 2014; 24(6): 697.
Ruzigana G, Bazzet-Matabele L, Rulisa S, Martin AN, Ghebre RG. Cervical cancer screening at a tertiary care center in Rwanda. Gynecologic Oncology Reports, (2017); 21: 13-6.
Assoumou SZ, Mabika Mabika B, Mbiguino AN, Mouallif M, Khattabi A, Ennaji M. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women. BMC Women's Health, (2015); 15(37):1-7.
Mohebi S, Sharifirad G, Gharlipour Z, Kamran A. The Study of Pap Smear Conduction and its Related Factors Based on Health Belief Model in Women Referring to Health Care Centers in Qom During 2014. Journal of Education and Community Health, (2016); 2 (4): 25-33.
Akinlotan M, Bolin JN, Helduser J, Ojinnaka C, Lichorad A, McClellan D. Cervical Cancer Screening Barriers and Risk Factor Knowledge Among Uninsured Women. Journal of Community Health, (2017); 1-12.
Chorley AJ, Marlow LAV, Forster AS, Haddrell JB, Waller J. Experiences of cervical screening and barriers to participation in the context of an organised programme: a systematic review and thematic synthesis. PsychoOncology, 2017; 72; 161.
Kasting ML, Wilson S, Zollinger TW, Dixon BE, Stupiansky NW, Zimet GD. Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses. Preventive Medicine Reports, (2017); 5: 169-74.
Gu C, Chan CWH, He GP, Choi KC, Yang SB. Chinese women’s motivation to receive future screening: The role of social-demographic factors, knowledge and risk perception of cervical cancer. European Journal of Oncology Nursing, (2013); 17: 154-61.
Mbachu C, Dim C, Ezeoke U. Effects of peer health education on perception and practice of screening forcervical cancer among urban residential women in southeast Nigeria: a before and after study. BMC women's health, (2017); 17(1): 41
Demirtas, B., Acikgoz, I. Promoting Attendance at Cervical Cancer Screening: Understanding the Relationship with Turkish Womens’ Health Beliefs. Asian Pacific Journal of Cancer Prevention, (2013); 14(1): 333-40.
DOI: http://dx.doi.org/10.62940/als.v9i3.1420
Refbacks
- There are currently no refbacks.